Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling
Biomolecules · 04.01.2023 · 13 (1) · 104
DOI: 10.3390/biom13010104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 04.01.2023. Verfasst von Qiqi Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiaosheng Wang, Linjun You.
Abstract (Originalsprache)
Background
The tumor immune microenvironment (TIME) of adrenocortical carcinoma (ACC) is heterogeneous. However, a classification of ACC based on the TIME remains unexplored.
Methods
We hierarchically clustered ACC based on the enrichment levels of twenty-three immune signatures to identify its immune-specific subtypes. Furthermore, we comprehensively compared the clinical and molecular profiles between the subtypes.
Results
We identified two immune-specific subtypes of ACC: Immunity-H and Immunity-L, which had high and low immune signature scores, respectively. We demonstrated that this subtyping method was stable and reproducible by analyzing five different ACC cohorts. Compared with Immunity-H, Immunity-L had lower levels of immune cell infiltration, worse overall and disease-free survival prognosis, and higher tumor stemness, genomic instability, proliferation potential, and intratumor heterogeneity. Furthermore, the ACC driver gene CTNNB1 was more frequently mutated in Immunity-L than in Immunity-H. Several proteins, such as mTOR, ERCC1, Akt, ACC1, Cyclin_E1, β-catenin, FASN, and GAPDH, were more highly expressed in Immunity-L than in Immunity-H. In contrast, p53, Syk, Lck, PREX1, and MAPK were more highly expressed in Immunity-H. Pathway and gene ontology analysis showed that the immune, stromal, and apoptosis pathways were highly enriched in Immunity-H, while the cell cycle, steroid biosynthesis, and DNA damage repair pathways were highly enriched in Immunity-L.
Conclusions
ACC can be classified into two stable immune-related subtypes, which have significantly different antitumor responses, molecular characteristics, and clinical outcomes. This subtyping may provide clinical implications for prognostic and immunotherapeutic stratification of ACC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China.
- Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198, China.
ORCID-Profile: Xiaosheng Wang
Förderung
- Xiaosheng Wang
- Linjun You
Zitieren
APA
Lu, Q., Nie, R., Luo, J., Wang, X., & You, L. (2023). Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling. Biomolecules, 13(1), 104. https://doi.org/10.3390/biom13010104
Vancouver
Lu Q, Nie R, Luo J, Wang X, You L. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling. Biomolecules. 2023;13(1):104. doi:10.3390/biom13010104
BibTeX
@article{Lu2023,
author = {Lu, Qiqi and Nie, Rongfang and Luo, Jiangti and Wang, Xiaosheng and You, Linjun},
title = {Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {1},
pages = {104},
doi = {10.3390/biom13010104}
}
EUVIMED